Researchers found that nearly 15% of commercially insured PrEP users had an alcohol use disorder diagnosis, yet fewer than 9% received FDA-approved treatment.
After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.
A MAHA commission report on child health cited several studies that could not be verified, leading to corrections and questions about sourcing accuracy.
Reuters
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Guidelines from the Department of Health and Human Services recommend statins as primary prevention for people with HIV aged 40 to 75 years who have a 10-year ASCVD risk of 5% or higher.
A new multicenter analysis of over 6,700 hospitalized older adults found that RSV vaccine uptake was low in its first season, with significant gaps in awareness and access, especially among socioeconomically vulnerable populations.